| Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity A Jaggupilli, E Elkord Journal of Immunology Research 2012, 2012 | 612 | 2012 |
| Bitter taste receptors: Novel insights into the biochemistry and pharmacology A Jaggupilli, R Howard, JD Upadhyaya, RP Bhullar, P Chelikani The international journal of biochemistry & cell biology 77, 184-196, 2016 | 101 | 2016 |
| Analysis of the expression of human bitter taste receptors in extraoral tissues A Jaggupilli, N Singh, J Upadhyaya, AS Sikarwar, M Arakawa, ... Molecular and cellular biochemistry 426, 137-147, 2017 | 77 | 2017 |
| Abscisic acid acts as a blocker of the bitter taste G protein-coupled receptor T2R4 SP Pydi, A Jaggupilli, KM Nelson, SR Abrams, RP Bhullar, MC Loewen, ... Biochemistry 54 (16), 2622-2631, 2015 | 53 | 2015 |
| Characterization of the binding sites for bacterial acyl homoserine lactones (AHLs) on human bitter taste receptors (T2Rs) A Jaggupilli, N Singh, VCD Jesus, K Duan, P Chelikani ACS Infectious Diseases 4 (7), 1146-1156, 2018 | 44 | 2018 |
| Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics A Jaggupilli, N Singh, VC De Jesus, MS Gounni, P Dhanaraj, P Chelikani The FASEB Journal 33 (1), 501-517, 2019 | 41 | 2019 |
| The pharmacochaperone activity of quinine on bitter taste receptors JD Upadhyaya, R Chakraborty, FA Shaik, A Jaggupilli, RP Bhullar, ... PLoS One 11 (5), e0156347, 2016 | 34 | 2016 |
| Plasticity of the ligand binding pocket in the bitter taste receptor T2R7 K Liu, A Jaggupilli, D Premnath, P Chelikani Biochimica et Biophysica Acta (BBA)-Biomembranes 1860 (5), 991-999, 2018 | 32 | 2018 |
| Structural commonality of C1q TNF‐related proteins and their potential to activate relaxin/insulin‐like family peptide receptor 1 signalling pathways in cancer cells T Klonisch, A Glogowska, T Thanasupawat, M Burg, J Krcek, M Pitz, ... British journal of pharmacology 174 (10), 1025-1033, 2017 | 31 | 2017 |
| Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML A Tyagi, S Ly, F El-Dana, B Yuan, A Jaggupilli, S Grimm, M Konopleva, ... Blood, The Journal of the American Society of Hematology 139 (18), 2782-2796, 2022 | 13 | 2022 |
| Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer A Jaggupilli, S Ly, K Nguyen, V Anand, B Yuan, F El-Dana, Y Yan, ... British journal of cancer 126 (4), 615-627, 2022 | 13 | 2022 |
| Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands A Jaggupilli, P Dhanaraj, A Pritchard, JL Sorensen, S Dakshinamurti, ... Molecular and Cellular Biochemistry 446 (1), 63-72, 2018 | 11 | 2018 |
| Advanced glycation end-products can activate or block bitter taste receptors A Jaggupilli, R Howard, RE Aluko, P Chelikani Nutrients 11 (6), 1317, 2019 | 9 | 2019 |
| Regulation of Rac1 GTPase activity by quinine through G-protein and bitter taste receptor T2R4 C Sidhu, A Jaggupilli, P Chelikani, RP Bhullar Molecular and cellular biochemistry 426, 129-136, 2017 | 9 | 2017 |
| Highly conserved intracellular H208 residue influences agonist selectivity in bitter taste receptor T2R14 FA Shaik, A Jaggupilli, P Chelikani Biochimica et Biophysica Acta (BBA)-Biomembranes 1861 (12), 183057, 2019 | 6 | 2019 |
| Extraoral expression and characterization of bitter taste receptors in Astyanax mexicanus (Mexican tetra fish) V Bhatia, VC de Jesus, FA Shaik, A Jaggupilli, N Singh, P Chelikani, ... FASEB BioAdvances 4 (9), 574, 2022 | 2 | 2022 |
| Characterization of Adenylyl Cyclase Isoform 6 Residues Interacting with Forskolin V Bhatia, S Maghsoudi, M Hinton, AY Bhagirath, N Singh, A Jaggupilli, ... Biology 12 (4), 572, 2023 | 1 | 2023 |
| AML-327 Novel Anti–B7-H3 Blocking Antibody Enhances NK Cell–Mediated Cytotoxicity and Improves Outcomes in AML-Bearing Mice A Tyagi, S Ly, F El-Dana, B Yuan, A Jaggupilli, S Grimm, L Bover, ... Clinical Lymphoma Myeloma and Leukemia 22, S236, 2022 | 1 | 2022 |
| Oxidative stress induces glutamine-dependent GD2+ triple negative breast cancer stem cells A Jaggupilli, SJ Ly, R Borkar, K Nguyen, B Yuan, N Putluri, M Andreeff, ... Cancer Research 80 (16_Supplement), 3801-3801, 2020 | 1 | 2020 |
| TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax A Tyagi, A Jaggupilli, S Ly, B Yuan, F El-Dana, VL Hegde, V Anand, ... Leukemia 38 (1), 82-95, 2024 | | 2024 |
Prashen ChelikaniUniversity of ManitobaVerified email at umanitoba.ca
